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Highlights 
 
 Screening synthesis conditions to attain MRI contrast agents for tumors 
detection.  
 Ascorbic acid coated magnetite (Mag-AA) was the most stable formulation.     
 MRI using clinical equipment suggests Mag-AA is efficient as T2 contrast agent. 
 Cell viability and up take on human colon cancer cells shows satisfactory results. 
 
Abstract 
 
Magnetic iron oxide nanoparticles (MNPs) have been prepared and stabilized with three 
organic acids (tartaric, malic and ascorbic) in order to obtain biocompatible and water 
dispersible MNPs with potential to bind specifically to tumoral cancer cells. An in deep 
characterization was performed aiming to verify the presence and effect of the coating and 
stabilizer on MNPs surface. Besides the mechanisms followed by the different acids to bind 
MNPs were elucidated and used to justify the differences in the physicochemical properties of 
each formulation. Data related to characterization revealed that MNPs coated ascorbic acid 
(MNPs-AA) resulted the most suitable in terms of their size, surface charge and stability along 
the time. Besides, ascorbic acid may be recognized by GLUTs receptors that are overexpressed 
in several kinds of tumoral cells. Therefore, MNPs-AA was selected to explore its performance 
in both MRI and in vitro assays using human colon cancer cells HCT 116. MRI experiments 
were performed in clinical equipment using a series of aqueous dispersions of MNPs-AA that 
were evaluated as T2 contrast agent. The T2- weighted images obtained as well as the 
calculated r2, indicated that MNPs-AA could act as efficient T2 contrast agent for MRI. 
Regarding in vitro assays, MNPs-AA did not alter the cellular function neither exert cytotoxicity 
using the three explored doses. The internalization of the nanoparticles on the cellular structure 
was confirmed quanti and qualitatively using atomic absorption spectroscopy and Prussian blue 
techniques respectively. 
From these results, it emerges that ascorbic acid coated-magnetite nanoparticles may be used 
as alternative contrast agent to avoid or minimize some toxicological issues related to the widely 
used gadolinium.  
 
Keywords: MAGNETITE NANOPARTICLES, ASCORBIC ACID, CONTRAST AGENTS, HUMAN 
COLON CANCER CELLS 
 
1. Introduction 
 
An urgent need for achieving early and selective diagnosis is actually recognized due 
to the severity of many pathologies such as cancer and cardiovascular diseases [1,2] . 
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At present, gadolinium derivatives are almost exclusively employed as contrast agent 
(CA) for MRI and have generally been considered safe when administrated in chelate 
forms. However, the use of gadolinium has been restricted in patients with acute renal 
dysfunction because of the risk of develop nephrogenic systematic fibrosis, in child and 
in other groups of health vulnerable patients [3,4]. In this view, MNPs with optimal 
characteristics, in terms of the contrast capability, size and size distribution, may be 
taken as a valid and safe alternative with these groups of patients [5,6].  
In fact, the application of iron oxide magnetic nanoparticles as CA have been widely 
reported, in particular as T2 CA [7]. In this concern, several CA based on iron oxides 
have been available in the market since the earlier 90´. Although most of them have 
been actually discontinued or withdrawn from the market for multiple reasons [8]. The 
possibility to coat the MNPs providing selectivity for a specific target, represents a great 
advantage regarding to the efficiency of these nanosystems to the early detection of 
diverse pathologies. Besides, recent literature is focusing on the dual capability of MNPs 
in the therapy and diagnostic of oncological diseases [9]. 
It has been proposed that nanoparticles intended for the recognition of cell surface 
receptors may represent an attractive way to the identification of tumor cells using MRI 
techniques[10].  
For example, magnetic nanoparticles were modified with hyaluronic acid as a selective 
ligand to CD44 receptors, which are overexpressed in different kind of cancer cells. In 
this way it would be possible the sensitive detection of such tumor cells  [11,12]. 
Hyaluronic acid coated magnetic nanoparticles have also been studied for imaging 
atherosclerosis [13]. The folate receptor is another interesting target because is 
overexpressed in cancer cells and activated macrophages. Liu et al conjugated folic 
acid to magnetic nanoparticles and succeeded in the separation of metastatic ovarian 
cancer cell from the bloodstream, despite the low concentration of them in blood [14]. 
Other recent studies involve the use of different compounds promoting specific 
interactions with receptors overexpressed in several pathologies aiming to assess an 
early detection by MRI [15,16].  
The aim of this work is to design MNPs with suitable properties able to be employed 
as contrast agents to assess the earlier diagnostic of high impact diseases, such as 
cancer, by MRI. To do this, magnetite nanoparticles were coated with: ascorbic, tartaric 
and malic acids. Since they are non-toxic compounds [17–19], biocompatible and 
hydrophilic nanoparticles could be obtained. In particular ascorbic acid deserves special 
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interest as a water-soluble vitamin with several implications in human health [19]. 
According to reported literature, numerous tumor cells overexpress the glucose 
transporters (GLUTs) which are implicated in the accumulation of ascorbic acid in 
tumors [20]. The mechanisms proposed for this accumulation include the extracellular 
oxidation of ascorbic to dehydroascorbic acid and the transportation of this form inside 
the tumor cell by the GLUTs transports. Once into the cell, dehydroascorbic acid is 
reduced and remains in its interior [21]. 
In this context, this contribution proposes a rigorous study of the synthetic pathways 
to achieve coated MNPs potentially useful as CA with suitable properties to be 
selectively employed in tumor detection by MRI. The performance of MNPs as contrast 
agents for MRI was studied using clinical equipment; whereas their cytotoxicity and 
internalization capability were assessed on HCT116 cells derived from human colon 
carcinoma.  
 
2. EXPERIMENTAL 
 
2.1.  Materials 
All reagents were of analytical grade and used without further purification. Ferric 
chloride hexahydrate was provided by Biopack (Argentina), ferrous sulphate 
heptahydrate was provided by Mallinckradt Chemical Works (USA). Sodium hydroxide 
was purchased from Cicarelli (Argentina).  
 
2.2. Methods 
 
2.2.1-Synthesis of Magnetic Nanoparticles  
 
The magnetite nanoparticles were synthesized by co-precipitation with some 
modifications regarding to the traditional methodology based on previous own works 
[22,23]. Briefly, 0.358 g of FeSO4 and 0.651 g of FeCl3 were dissolved in 20 ml of 
distilled water in a thermostatized reactor at 60ºC under nitrogen atmosphere. A 
stabilizer was added to the Fe2+/Fe3+ aqueous solution (an organic acid or PEG, see 
Table S1). Then, an alkali solution was employed to precipitate magnetite. The resulting 
suspension was stirred during 45 minutes. The purification was assessed by cycles of 
washing with distilled water and magnetic decantation until pH and conductivity reached 
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the levels roughly comparable with the one corresponding to distilled water. This allows 
inferring that not free acids or alkali ions were present in the supernatant, so that the 
obtained coated-magnetic nanoparticles were purified.   
The particular experimental conditions applied to prepare tartaric (Mag-TA); malic 
(Mag-MA) and ascorbic acid (Mag-AA1) coated-magnetite are depicted in 
supplementary material.  
 
2.3. Characterization  
 
Fourier Transform Spectroscopy (FTIR) spectra were recorded in a Thermos 
Scientific Nicolet iS50 in the frequency range of 400-4000 cm-1, using the KBr pellet 
method. Transmission Electron Microscopy (TEM, JEOL 100 CX II, Tokyo, Japan) was 
used to determine particle size and morphology of the nanoparticles. HRTEM images 
were achieved on a TEM-FEG (JEM 2100F) field-emission gun transmission electron 
microscope (voltage: 200 V, spot size 3). The images where acquired using a Gatan 
831.J45M0 camera at different resolution. The images where analyzed using ImageJ 
free software.   
X-ray diffraction (XRD) pattern of the nanoparticles were recorded using Cu-
Kα radiation on Rigaku D-Max III-C diffraction spectrometer with a graphite 
monochromator. 
Thermogravimetric analysis (TG) was performed in a TA Q600 equipment. Samples 
were weighted (30 mg) and heated at room temperature up to 650ºC at a rate about 
10ºC/min under air atmosphere.  
Data on hydrodynamic diameter and Z potential (ζ) were acquired in a Malvern 
Zetasizer (Nano-Zs90). Samples were dispersed in distilled water and sonicated for one 
hour before performing the acquisition.  
Magnetic measurements were performed using vibrating sample magnetometer 
(VSM)  
 
2.4. Magnetic Resonance Imaging (MRI) 
 
Contrast studies were performed in a clinical whole-body MRI scanner (Philips 
Achieva 1,5T). The MNPs sample was diluted in bidistilled water to obtain suspensions 
in the range from 0.5 to 0.6 mmol of Fe/ml. T2 weighted images was acquired using spin 
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echo (SE) pulse sequence. The time echo (TE) was ranged between 80 and 350 ms 
and the TR was maintained constant at 4000 ms.   
 
2.5. In vitro assays  
 
2.5.1. Cell culture  
 
The human colorectal cell line HCT116 (from the American Type Culture Collection, 
Manassas, Virginia) was cultured at 37 °C in DMEM (Sigma-Aldrich Chemical Co., St. 
Louis, Missouri, USA) containing 10% FBS (Natocor, Córdoba, Argentina), 1% non-
essential acids, 100 UI/mL penicillin, 100 mg/mL streptomycin and 50 mg/mL 
gentamycin in a humid atmosphere of 5% CO2 in air. Cultures were treated every 2 days 
with fresh medium. All experiments were performed using passages less than 15. Cells 
were incubated in presence/absence of MNPs (which were previously sterilized by UV 
irradiation) at different concentrations.  
 
2.5.2. Cytotoxicity evaluation 
 
The impact of MNPs on the viability of HCT116 cells culture was evaluated using a 
standard MTS cell viability assay (Promega, Madison, WI). Briefly, cells were seeded 
for quadruplicate in 96 well plates at 2 ×103 cells/well. Culture medium was removed 
and replaced by a suspension of MNPs (1, 10 or 100 μg Fe/ml) in DMEM 10% SFB. 
After incubation, the culture medium was removed, replaced by fresh DMEM without 
phenol red (Sigma-Aldrich Chemical Co., St. Louis, Missouri, USA) containing 10 μl of 
MTS reagent and after 10 minutes, the absorbance at 490 nm was recorded using a 
Biotek Synergy HT MicroplateReader. 
 
2.5.3. Internalization measurements 
 
a- Qualitative internalization assays by Prussian blue staining 
 
2 x 104 HCT116 cells were grown in coverslips, for 24 hours, and incubated with a 
suspension of MNPs (10 or 100 μg Fe/ml) carried in fresh culture medium, during 24hs. 
Cells were washed and fixed with 4% paraformaldehyde and exposed to 5% 
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K4Fe(CN)6/1% HCl and counterstained with Giemsa. Slides were observed using an 
optic microscope equipped with an Olympus camera.  
 
b-Quantitative internalization by Atomic absorption measurements 
 
The presence of MNPs on the cells was determined by measuring the Fe content.7 x 
104 HCT116 cells/well were grown in 6-well plates, and incubated with a suspension of 
MNPs (1, 10 or 100 μg Fe/ml). After 24 hours, the supernatant of each well was 
collected and treated with HCl 10%.  Cells were detached from the wells with trypsin, 
resuspended and centrifuged. Cells supernatant and cell pellets were treated with HCl 
10%. The solutions were sonicated to ensure that all iron was released from magnetite. 
Afterwards, iron concentration was measured for each fraction by atomic absorption 
spectroscopy. Finally, cellular uptake of MNPs was calculated from the internalized 
amount of MNPs normalized to the total incubated amount of MNPs, both expressed as 
µg of MNPs, according the following formula: 
 
%Cellular uptake = Internalized amount of MNPs x100/ Total incubated amount of 
MNPs 
 
3. Results and discussion  
 
3.1. Synthesis and characterization of magnetic nanoparticles 
 
3.1.1. FTIR analysis 
 
Figure 1a shows IR spectra of three raw acids and Figure 1b those corresponding 
to MAG coated with TA, MA and AA respectively. The spectrum of Mag-TA confirming 
the incorporation of the organic acid on the iron surface by the presence of carbonyl 
band assigned to the acid. The stretching signal of C=O shifted from 1734 cm-1 in pure 
tartaric acid to 1648 cm-1 in Mag-TA, revealing that the interaction is given by C=O acidic 
group and Fe atoms in the particles surface [24].  
The stretching band of C-O corresponding to the alcohol functional group at 1060 
cm-1 is also observable in Mag-TA spectrum. Whereas the stretching band of Fe-O from 
iron oxide appears at 592 cm-1. 
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Comparing the spectra of Mag-MA with the corresponding to raw MA, it may infer 
that the MA was linked to the magnetite surface. The signal of C=O assigned to MA is 
observed in Mag-MA spectrum although shifted to lower wavenumber (1625 cm-1) with 
respect to MA spectrum (1740 cm-1). This may be due to MAG interactions. Two bands 
at 1384 and 1054 cm-1 are also distinguished and may be ascribed to the stretching 
vibrations of C-H and C-O respectively. 
From IR spectra of pure ascorbic acid and Mag-AA1, it is possible observe that the 
stretching vibration of C=O group of ascorbic acid observed at 1756 cm-1 in raw AA, is 
also shifted to 1631 cm-1 in Mag-AA1, indicating the surface MAG modification. It is 
worth noting that C=C signal appears at 1675 cm-1 in AA spectrum, but it is not clearly 
distinguished in Mag-AA1 spectrum. This could be due to the reduction of the C=C to 
form the dehydroascorbic acid [25]. It is also feasible that C=C band overlaps with the 
corresponding to C=O, limiting its detection.  
Besides, other bands corresponding to the stretching vibration of O-H at 3409 cm-1, 
stretching of C-H at 2930 cm-1 and those associated to the deformation vibration of C-
H at 1389-1324 cm-1 may be distinguished in the spectrum of Mag-AA1. The signals 
observed at 1120 and 1014 cm-1 ascribed to alcoholic C-O, in combination with those 
earlier described, reveal the effective incorporation of AA on the MAG surface[25]. The 
typical Fe-O band from magnetite is also observed around 583cm-1. 
 
3.1.2. Measurements of Z potential, hydrodynamic diameters and morphology by TEM  
 
The hydrodynamic diameter and z potential data of the coated-MNPs as well as naked 
magnetite are listed in Table 1. Data on the Table indicate a high reduction of the 
hydrodynamic diameter because of the organic acids coating on MAG surface. These 
findings highlight the stabilizing effect of the selected acids on the MAG in aqueous 
dispersion. 
The zeta potential of the samples was measured at pH 6.1-6.8 and provides information 
about the surface charge of MNPs. Hence, it may be taken as a measurement of the 
stability of colloidal dispersion, since it is responsible for the degree of electrostatic 
repulsive forces between particles. Therefore, the increment in  magnitude observed in 
coated MNPs in relation to naked magnetite, suggests that an effective electrostatic 
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stabilization was achieved. The enhanced in the negative value is in agreement with 
the presence of carboxylate groups in MNP surface.   
 
 
It is worth mention that both, TA and MA, have two carboxylic acids groups with pKas 
around 3.04 and 4.37; and 3.4 and 5.11, respectively [26,27]. 
The  value of Mag-AA is related to the presence of two ionizable hydroxyl groups, 
one of them with a pKa 4.2 [28]. These results confirm the presence of the acid in the 
magnetic iron oxide surface, supporting the FTIR data.  
Regarding to the morphology, all prepared MAG formulations resulted almost 
spherical and uniform in shape, as it is observed in Figure 2. Noticeable differences are 
appreciated by comparing the sizes estimated by dynamic light scattering and TEM, 
respectively. This is consistent with the principle of each method, considering that the 
hydrodynamic sizes are recorded by DLS and include the measure of aggregates of 
nanoparticles in dispersion [22].  
 
Table 1. Data on hydrodynamic size, TEM estimated size and as a function of the coating. 
 
3.1.3. Thermal analysis and XRD data 
The magnetite crystalline pattern is clearly distinguished in Mag-MA and Mag-AA1 
diffractograms, as it is shown in Figure 3a. On the other hand, the characteristic’s MAG 
peaks are barely distinguished in Mag-TA diffractogram (see Figure 3a). Broad signal 
was obtained, probably due to the formation of a tartrate-Fe complex, interfering in 
magnetite’s precipitation and crystallization. Tartaric acid is recognized as iron chelating 
agent, favoring the occurrence of tartrate-Fe coordination bonds. The mechanism 
generally accepted for the formation of magnetite through the co-precipitation method 
is well known and described by the following equations [23]:  
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 Tartrate ion would participate in the earlier steps, by restricting the Fe(OH)3 
precipitation (Equation 1). Hence it is possible that the formation of a mixture of Fe-
tartrate species and other iron oxides occur  in the alkaline reaction media [29]. In fact, 
the first synthesis conducted using 600 mg of tartaric acid (the same amount used for 
Mag-MA and Mag-AA1 synthesis) yielded a non-magnetic product. Increasing the 
amount of tartaric acid could favor the predominant formation of iron-complex instead 
of the stabilized magnetic iron oxide [30]. Other authors have reported similar 
observations, where the presence of analogous acids, such as oxalic in almost similar 
experimental conditions, rendered lepidocrosite or akageneite instead of magnetite. 
[31]. 
Thermogravimetric curves of Mag-MA (data not show included in Supplementary 
Material, S1) shows three steps-loss: one associated to loss of water at 100ºC; and two 
steps related to the decomposition of malic acid. It has been reported that MA has a 
wide decomposition range, ending at 275ºC [32]. In the case of Mag-MA this ending is 
found at 340ºC, and may be ascribed to the MA linkage on the magnetic core. Other 
authors have found similar trends. Prakash et al reported that the weight loss of MA 
bonded on nanocrystalline hydroxyapatite occurs between 200 and 600º [33].  
From this analysis, it may infer that the mass loss associated to the organic fraction 
reached around 4%. This result corresponds with the one recorded by atomic 
absorption, that was roughly about 6%.   
Thermogravimetric curves of Mag-AA1 (Figure S1b) shows the step-loss of water at 
100ºC and a step-loss starting at 180ºC (the initial temperature decomposition of AA 
under air) [34]. The total weight loss due to the organic fraction was about 6%. From 
the atomic absorption measurement, it was determined that the amount of magnetite in 
the sample was 90%. Hence, already a 10% may be assumed that corresponds to the 
organic fraction, in agreement with the TG data.  
 
3.1.4. Magnetic measurements 
 
The Figure 3b includes the data registered from VSM measurements of all the 
prepared MNPs. Mag-TA exhibits a very low magnetization to saturation value when 
compared with Mag-MA and Mag-AA whose value is almost in the range of other Mag 
coated nanoparticles [35–37]. This finding may be justified in terms of the formation of 
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other non-magnetic iron oxide such as lepidocrosite or akageneite supporting the XRD 
data.   
 Mag-MA and Mag-AA1 magnetization curves reveal a superparamagnetic behavior 
(Figure 3b). Curves were fitted with a Langevin function (red line) and negligible 
coercitivity is observed. This behavior is possible in nanoparticles whose size is smaller 
than 25 nm [38]. Superparamagnetism is an important property for MNPs intended for 
biological applications [39]. The magnetization to saturation values are lower than the 
corresponding to bare magnetite [40] due to surface coated with the organic material 
[40,41].  
Sizes of magnetic core were estimated from VSM data following the procedure 
described in reference [42]. These values of about 3.7 and 3.8 nm for Mag-MA and 
Mag-AA1 respectively, roughly coincide with the sizes estimated by TEM as an 
approximation.  
 
3.1.5. Selection of the most suitable coated MAG formulation 
 
In view of the data arising from the characterization, it is clear that either Mag-MA or 
Mag-AA1 would result in efficient nanocarriers to assess both the diagnostic and 
subsequent target to the interest biomarkers. In spite of having similar characteristics in 
terms of size and zeta potential, Mag-AA1 demonstrated to be more stable in 
suspension than Mag-MA, over time. This last one, precipitated after 12 hours in 
aqueous dispersion, while Mag-AA1 kept in suspension for weeks without suffering 
great deviations from their original hydrodynamic size. Besides, the mechanism for AA 
to act as selective ligand in tumoral environment is well identified involving the 
interaction with GLUTs receptors overexpressed in several kinds of tumoral cells.  
In this regards, a deeper study was developed aiming to ensure a suitable AA coating 
to the desired applications. 
 
3.1.5.1-Influence of the initial AA concentration  
 
The effect of different initial amounts of AA was explored aiming to: i-Ensure an 
enough concentration of the acid on MAG surface to accomplish the target function; ii-
to improve physicochemical properties such as size, size distribution and fundamentally 
their stability in media simulating the physiological environment. 
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The Figure 4a depicts the evolution of Hydrodynamic diameter and Z potential as a 
function of the AA concentration initially added to the MAG nanoparticles. An almost 
linear trend between negative surface charge and AA concentration is almost observed. 
The negative surface charge increases with higher AA nominal concentrations. This is 
consistent with published works, that demonstrate that higher colloidal stabilization was 
achieved in aqueous media by increasing the amount of stabilizers [43,44]. 
On the other hand, the hydrodynamic diameter seems not to be sensitive to the 
variation of AA amount. The HD reaches almost a constant value by using different AA 
concentrations. The same is observed by examining the morphology of nanoparticles. 
Increasing AA nominal concentration seems not to affect the size and shape of MNPs. 
Figure 4b shows HR TEM images of MAG-AA3 to illustrate. From those images is easy 
to see a well spherical shape of the nanoparticles and the corresponding AA coating. In 
addition, no agglomerations are detected and a few nanometers distance between 
nanoparticles is evidenced. The high resolution microscopy also confirms the 
crystallinity of the particles (see Figure 4b). From fast Fourier transform (FFT) was 
possible to estimate the distance between the Bragg planes consistent with the 
expected for the (0,2,4) interplanar distance of Fe3O4.  
The use of higher AA amounts did not alter the magnetic properties of nanoparticles 
as reveal the saturation magnetization values (Supplementary Material, S4). In fact, 
almost similar values were recorded in the three formulations. The magnetic core sizes 
determined by VSM data also resulted already constant for all AA formulations (around 
4-5 nm). 
The incorporation of PEG on the co-precipitation media resulted crucial to attain MAG-
AA with suitable properties for biomedical intends. The addition of PEG instead of 
ascorbic acid to the co-precipitation media was implemented exclusively for stabilization 
ends. It is well known that the vitamin may reduce Fe3+ leading to an alteration in the 
Fe3+/Fe2+ ratio required to achieve magnetite [45,46].Therefore, the coating with 
ascorbic acid was performed in a posterior step after the precipitation of iron oxide 
nanoparticles. 
Findings related to FTIR reveal that PEG is not binding to the particles surface, 
because its stabilization mechanism is by steric hindrance in the dispersion media [43].  
 
3.2. Magnetic Resonance Imaging (MRI) 
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In order to evaluate the performance of Mag-AA3 as contrast agent, T2-weighted MRI 
images were explored using a series of MNPs dispersions with concentrations ranging 
between 0.05 to 0.6 mM Fe. These doses were selected based on published articles in 
open literature studying analogous nanosystems [25]. The Figure 5a shows the data 
acquired from different Mag-AA3 aqueous dispersions in T2-weighted images. From 
this, it is evident that the intensity falls in T2-weighted images as the concentration of 
Mag-AA3 in the dispersions increases. Darker images were obtained as the 
concentration of the nanoparticles increased. Signal intensity for each concentration 
was determined by manually drawn a region of interest (ROI). By plotting the ROI vs 
the TE, T2 relaxation curves were obtained (data included in supplementary material, 
S6). The curve shows that as the concentration of the nanoparticles increase from 0.05 
to 0.4 Mm Fe, the curve become steeper showing that Mag-AA3 is shortening the T2 
relaxation time [47,48]. Apparently, when the dose increase to 0.6 mM Fe the effect on 
signal intensity is lower than with the dose of 0.4 mM. To justify this behavior, the 
relation between signal intensity and the concentration of Mag-AA3 has to be 
considered (data included in supplementary material, S7). The data on the figure 
suggest that a reduction of 41% in signal intensity is reached by using a dispersion 
containing 0.05 mM Fe from Mag-AA3. The signal intensity exhibits an intense fall of 
about 99.25% when a dispersion of 0.2 mM of Fe is employed. In all measurements the 
evolution of the signal intensity was monitored using distilled water as reference. From 
this analysis, it may infer that using a limit concentration of 0.2 mM Fe, the system 
reaches an almost steady state though that signal intensity exhibits an almost constant 
value, independently on the dispersion concentration (see Table S3 supplementary 
material). In fact, the assays performed using higher concentration of dispersion (i.e 
0.6Mm) leaded to inconsistent signal intensity data.  
To evaluate the efficiency of MAG-AA3 to act as T2 contrast agent, the relaxivity r2 
was determined by plotting the transverse relaxation rate (1/T2) vs iron concentration. 
Figure 5b depict that the data follows a linear tendency. From this plot, the r2 value 
was obtained as the slope of the curve. The found relaxivity value was 198 mM-1.s-1, 
which is significantly higher than the one reported for the FDA-approved Ferumoxtran-
10, whose measured relaxivity value at 1.5 T was 60 mM-1s-1[28,49]. The improved 
constrast properties, given by the high r2 value measured, may be ascribed to the 
physical and morphological characteristics of the MNPs. The size of MAG-AA3 is 
suitable to contrast in T2-weighted images [50]. Besides, as it was determined by TGA 
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and atomic absorption spectroscopy, the coating surrounding the magnetic core is not 
thicker enough. This property improved the interactions between water protons and the 
magnetic surface [51]. Based on the obtained data, MAG-AA3 could be considered as 
an efficient T2 contrast agent. These assays constitute the needed in vitro preliminary 
step, since were measured in simulated physiological environment.  
It is worth noting that properties of these nanoparticles, such as size, are satisfactory 
to ensure their performance as T2 contrast agent. Examples found in open literature 
deal with larger nanoparticles tested as negative contrast agents. For example, 
Taboada et al observed that silica coated-magnetic nanoparticles with a hydrodynamic 
diameter of 300 nm and r2 value of 326 mM-1s-1exhibit a great performance as T2 
contrast agent [52]. In fact, the informed r2 value corresponds to twice the value of 
Endorem®. The authors proposed that the largest magnetic nucleus induce larger 
magnetic inhomogeneities, reducing the T2 time, which may lead to a higher efficiency.  
The following instance will be the in vivo MRI studies to corroborate their efficiency 
and biosafety.  
 
 In vitro assays 
 
3.2.1. Biocompatibility of MNPs 
 
MTS was employed to evaluate cell viability after exposure to Mag-AA3. Only living 
cells are able to reduce the MTS. The product of such reduction may be quantified 
spectrophotometrically after dissolution in DMSO at 490 nm. The data obtained from 
this assay are considered indicators of cell survival [53]. 
Figure 6a shows the absorbance recorded at 490 nm using the three explored doses 
during two fixed times (i.e. 24 and 48hs). From the Figure appears that the cell viability 
was not affected by the presence of the particles after 24 and 48 hours, using any of 
the three assayed doses (1, 10 and 100 μg MNPs/ml). 
When MNPs interact with the cell, they can influence the cellular processes, causing 
cell stress, by changing the metabolic activity, inducing oxidative stress and 
cytoskeleton disruption, or through DNA damage [54]. The toxicity of iron oxide particles 
varies between particle and cell type and depends on many factors, being the 
physicochemical properties of MNPs the key one [55]. Some discrepancies are found 
in open literature regarding the source of toxicity exerted by MNPs. Numerous studies 
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examining the impact iron oxide nanoparticles in vitro suggest that the toxicity is related 
to the nature of the coating and experimental conditions; without evidences to toxic 
effects induced by the magnetic core (maghemite or magnetite) [56]. On the other hand, 
other researchers report that the magnetic component may induce oxidative stress 
associated to high Fe concentrations. In general, the cytotoxicity attributed to MNPs is 
considered dose-dependent [57] and it is associated to an imbalance of cytoplasmic 
iron ions which may cause oxidative stress leading to cellular toxicity, impaired cell 
metabolism, and concomitant increment in apoptosis [58].  
In such cases the level and nature of the coating material is considered a valid tool to 
minimize the toxic effects. In the present work, the selection of AA as coating offered 
several advantages such as its biodisponibility, low cost and biosafety. Besides, its 
effect as biocompatibility enhancer has been reported including in vivo assays by 
increasing cellular absorption of iron and decreasing their toxicity [59]. 
Moreover, as further qualitative evidence, the nanoparticles were visualized inside 
cells by bright field microscopy (see supplementary material, Figure S8). The image 
corresponds to the cells treated with the dose of 100 μg/ml, where the nanoparticles 
may be identified as light brown spots inside the cells. From the data on the Figure 6a 
and S6, it may infer that Mag-AA is not affecting the cell division or metabolic capacity 
of these cells even when the highest doses and incubation times are employed.  
The toxicity of magnetic nanoparticles has been reported as dependent on size, 
surface charge and nature of coating. To assess the toxicity of nanoparticles not only in 
vitro but also in vivo studies should be performed. The former ones usually determine 
higher toxicity than the latest one. This is because during in vivo experiments possible 
toxic degradation products can be continuously eliminated from the body [60]. Future in 
vivo test are needed to determine the authentic potential toxicity of Mag-AA3, as well 
as their biodistribution. Those investigations will be matter of a next separate work. 
 
3.2.2. Uptake of AA-Mag4 MNPs by HCT116 cells 
 
Prussian blue staining was employed to gain information on the MNPs uptake on HCT 
116 cell. This staining method makes particles blue, and gives suitable contrast in the 
optical microscopes allowing a preliminary evaluation of the particles labeling efficacy. 
The results are depicted in Figure 6b indicating MNPs containing sites as light blue 
spots. MNPs internalized via formation of ferric ferrocyanide, by the reaction of Fe3+ with 
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K4Fe(CN)6 and the effect was determined as dose dependent. That means that the 
highest MNPs doses (100 μg Fe/ml Mag-AA3) leaded to a cell labeling efficiency of 
about 100%. Other authors have reported similar findings concerning the dose 
dependent up take level; and besides have shown the importance of the MNPs surface 
charge and coating in the up take efficiency [61]. Although it has been reported that 
positively charged nanoparticles are better internalized by cells, negatively charged 
ones, has been associated with lower toxicity[61]. 
In addition, iron determination inside the cell was achieved using atomic absorption 
spectroscopy as a complement of the qualitative determination by Prussian blue [62]. 
The Fe contents measured in cell pellets and cell supernatant are listed in Table 2.  
 
Table 2. Iron content (Fe μg/ml) and the magnetite arising from it, from HCT116 cell cultures after 
incubation with different doses of Mag-AA. Percentage of cellular uptake is also shown.  
 
The data on the table indicate that lower Mag-AA3 doses supply an undetectable 
amount of Fe on the cell structure, at least using atomic absorption spectroscopy. The 
highest doses ensured the presence of iron in almost all the isolated cell fractions. The 
results agree Prussian Blue observations, where more blue spots were detected with 
the dose of 100 μg/ml compared with the dose of 10 μg/ml. 
The amount of Mag-AA3 found in cell supernatant could be considered as 
nanoparticles adsorbed on cellular surface. On the other hand, iron measured in cell 
pellets corresponds certainly  to internalized nanoparticles [62]. Based on the data from 
atomic absorption spectroscopy, a quantitative measurement on the MNPs 
internalization may be achieved by using the highest dose. The sum of the cellular 
fractions (supernatant and pellets) revealed that a 17.75% of the total nanoparticles 
labelled the cells. From these nanoparticles, 36.6% were internalized while 63.4% 
remained adsorbed in cell surface.  
As iron was not detected in all doses and fractions analyzed, it is not possible infer a 
trend regarding the dependency of nanoparticles dose. Even when the doses appears 
to be a key factor on the up take efficiency other factors such as hydrodynamic size, 
stability on the physiological media, cell type, number of treated cells and the duration 
of the experiment must also be considered to assess a rigorous analysis [63].  
 
4. Concluding remarks  
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 Water dispersible magnetic nanoparticles coated with organic acids were achieved by 
acutely adjusting the reaction conditions using co-precipitation method. The best 
formulation in terms of size and stability was the AA coated Mag, showing a stable 
hydrodynamic size during already three months. Mag-MA resulted in suitable properties 
concerning to size and surface charge but limited stability (already 12hs), being 
unsuitable for the desired applications. 
Mag-AA formulations where explored in terms of the initial AA concentration, being 
MAG-AA3 the most suitable one. This formulation demonstrated to be efficient in 
generating the negative T2 contrast as demonstrated the assays performed in the 
clinical RMI equipment.  
In vitro assays on cancer colon rectal cell culture indicated that the cell viability was 
not affected even when incubating high concentrations of nanoparticles for 48 h. 
Besides, the Mag-AA3 uptake on HCT116 cells was demonstrated by two independent 
techniques, revealing the efficient MNPs internalization mainly at high-administrated 
doses. 
The experiments carried out are the required preliminary stage in view of the future in 
vivo application in animal models to really validate the proposed magnetic formulation.  
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Figure 1. a) IR spectra of raw acids. b) IR spectra of the stabilized MNPs with AA, MA and TA. 
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Figure 2. TEM micrographies of Mag-TA, Mag-MA and Mag-AA nanoparticles. 
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Figure 3. a) XRD difractograms of Mag-TA, Mag-MA and Mag-AA1. b) Magnetic measurements by VSM 
of Mag-TA-Mag-MA and Mag-AA1. 
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Figure 4. a) Hydrodynamic diameter (PDI: 0.218; 0.137; and 0.185 using 300, 600 and 900 mg of 
ascorbic acid respectively) and Z potential as a function of the nominal AA concentration. b) HR TEM of 
Mag-AA. 
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Figure 5. a) T2-weighted images of Mag-AA3 with a TE= 250ms and TR= 2000ms. b) Transverse 
relaxation rate vs iron concentration, the slope represents r2.    
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Figure 6.  a) Cell viability assay results for HCT116 cell line after 24h Mag-AA3 nanoparticles. Data is 
expressed as mean ± standard deviation of two independent experiments. b) Prussian Blue staining in 
HCT116 cells treated with different concentrations of Mag-AA3 nanoparticles. Magnification 400x. 
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Table 1. Data on hydrodynamic diameter by DLS with the corresponding PDI and TEM estimated 
magnetic core size as a function of the coating. 
 
Formulation TEM 
estimated 
diameter 
(nm) 
Hydrodynamic 
diameter (nm) 
PDI 
 (mv) 
Naked 
Magnetite * 
n.d 417 0.252 -8.48 
Mag-TA 7.5 ±  0.05 148.1± 3.94 0.228 -28 ±  0.15 
Mag-MA 8.5 ± 1.55 94.8 ±  3.74 0.141 -17,1± 2.40 
Mag-AA1 8.5 ± 1.86 143.1±  14.2 0.137 -18.6 ±  
1.36 
*Ref: [43] 
n.d: Not determined due to the presence of large aggregates 
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Table 2. Iron content (Fe μg/ml) and the MNPs arising from it, from HCT116 cell cultures after 
incubation with different doses of Mag-AA. Percentage of cellular uptake is also shown.  
Sample Fe (μg/ml) μg of MNPs* % MNPs cell 
uptake 
Cell supernatant control  No detected ----- ---- 
Cell supernatant 1 μg/ml  No detected ----- ---- 
Cell supernatant 10 μg/ml  0.07 1,1 5.5% 
Cell supernatant 100 
μg/ml 
1.63 24.7 12.35% 
Cells pellts control No detected ----- ---- 
Cells pellets 1 μg/ml No detected ----- ---- 
Cells pellets 10 μg/ml No detected ----- ---- 
Cells pellets 100 μg/ml 1 15 7.5% 
*In 10mL that represents the total volume of each sample 
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